← Open Payments lookup

CARLA ODOM: Open Payments

NPI 1043827900 · KOKOMO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296 in 14 payments from 8 companies in 2025. Trend: 2023 $168 · 2024 $197 · 2025 $296

Food & beverage: $296
CompanyPaymentsAmount
Novo Nordisk Inc2$81
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$67
Lilly USA, LLC3$56
Amgen Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Xeris Pharmaceuticals, Inc.1$16
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Phathom Pharmaceuticals, Inc.1$3

Products named: XIFAXAN, Wegovy, MOUNJARO, REPATHA, CAPLYTA, Ozempic, OTEZLA, GVOKE HYPOPEN.

Industry payments across MS — which companies pay providers there.